Jupiter Diagnostics

Jupiter Diagnostics

Jupiter Diagnostics has developed a diagnostic platform.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

€0.0

round
investor

€0.0

round
N/A

€0.0

round
N/A

£2.5m

Series A
Total Funding000k
Notes (0)
More about Jupiter Diagnostics
Made with AI
Edit

Jupiter Diagnostics, founded in 2015, is a developer of nano-crystal labeled technology aimed at providing high-quality, affordable blood testing for medical diagnostics. The company is headquartered in London, United Kingdom, and operates within the Laboratory Services (Healthcare) industry. The firm was established to address the inefficiencies and costs associated with traditional blood testing by moving the process closer to clinicians and patients, such as in wards, clinics, and pharmacies. This approach facilitates more convenient and ready access to common blood tests, enabling faster and better-informed healthcare decisions.

The company was founded by Chris Ball, who now serves as CEO. His background includes launching point-of-care diagnostic tests for Johnson & Johnson in Europe, serving as CEO of a Boston-based biotech company, and working as a venture capital investor and a medical doctor. He has successfully raised over £40 million for companies he has supported or led. Other key figures include CTO Gareth Jones, who has extensive experience in creating and advising on novel diagnostic technologies for UK firms, and Chairman Richard Sandberg, who founded Dianon Systems, a major US pathology service later sold to LabCorp.

Jupiter Diagnostics' core offering is the Calisto Multitest Reader, a portable, hand-held, rechargeable point-of-care device designed to deliver lab-quality blood test results within 10 minutes. The device utilizes fluorescence detection to measure up to eight analytes simultaneously. It was developed to be user-friendly with an intuitive process and a clear graphical user interface that allows clinicians remote and secure data access via a web service. The business aims to provide clinicians access to reliable and timely blood tests, initially focusing on fertility clinics, to allow for quicker diagnosis and treatment. Jupiter Diagnostics has raised a total of $2.48M in funding.

Keywords: point-of-care diagnostics, blood testing, medical devices, healthcare technology, clinical diagnostics, laboratory services, nano-crystal technology, fluorescence detection, Calisto Multitest Reader, portable diagnostics

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo

Investments by Jupiter Diagnostics

Edit
L3 Technology
ACQUISITION by Jupiter Diagnostics Dec 2016